8 Other specified nutritional anemias Anemia associated with deficiency of copper Anemia associated with deficiency of molybdenum Anemia associated with deficiency of zinc Excludes1: nutritional deficiencies without anemia, such as: copper deficiency NOS (E61.0) molybdenum deficiency NOS (E61.5) zinc deficiency NOS (E60) D53.9 Nutritional anemia, unspecified Simple chronic anemia Excludes1: anemia NOS (D64.9) Hemolytic anemias (D55-D59) D55 Anemia due to enzyme disorders Excludes1: drug-induced enzyme deficiency anemia (D59.2) D55.0 Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency Favism G6PD deficiency anemia D55.1 Anemia due to other disorders of glutathione metabolism Anemia (due to) enzyme deficiencies, except G6PD, related to the hexose monophosphate [HMP] shunt pathway Anemia (due to) hemolytic nonspherocytic (hereditary), type I D55.2 Anemia due to disorders of glycolytic enzymes Hemolytic nonspherocytic (hereditary) anemia, type II Hexokinase deficiency anemia Pyruvate kinase [PK] deficiency anemia Triose-phosphate isomerase deficiency anemia Excludes1: disorders of glycolysis not associated with anemia (E74.8) D55.3 Anemia due to disorders of nucleotide metabolism D55.8 Other anemias due to enzyme disorders D55.9 Anemia due to enzyme disorder, unspecified D56 Thalassemia Excludes1: sickle-cell thalassemia (D57.4-) D56.0 Alpha thalassemia Alpha thalassemia major Hemoglobin H disease Severe alpha thalassemia Triple gene defect alpha thalassemia Excludes1: alpha thalassemia minor (D56.3) asymptomatic alpha thalassemia (D56.3) hydrops fetalis due to hemolytic disease (P56.-) D56.1 Beta thalassemia Beta thalassemia major Cooley'
Lesional tissue demonstrates elevated levels of RvD5, PDX, AT-LXA4, and AT-LXB4, whereas only PD1 is detectable in healthy skin [276], suggesting altered lipid mediator signaling in PSO
91, 34823485.10.1210/jc.2006-0368 93 WalenkampM
HO-1 is the primary endogenous source of CO, which acts as a key second messenger in the central nervous system (CNS)
(2024) J Expo Sci Environ Epidemiol, 34: 3., and per- and poly-fluoroalkyl substances (PFAS), a group of endocrine-disrupting chemicals (EDCs) that have been shown to increase the risk of certain cancers, such as thyroid, ovarian, and breast cancers (see Sidebar 22 ) (318)van Gerwen M, et al
